This small cap pharmaceuticals company has risen 13% after announcing its Q2 result.

About the company

[{"selector":"#anim-c19deb20-feae-4b7d-96ea-373d301bb6d3","keyframes":{"opacity":[0,1]},"delay":5,"duration":2500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-061a1485-3589-458a-ba60-98291fa2eb40","keyframes":{"transform":["translate3d(0px, 136.95988%, 0)","translate3d(0px, 0px, 0)"]},"delay":5,"duration":2500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Quarter 2 Result

[{"selector":"#anim-fc504e20-eff7-48db-acc0-841f8c659093","keyframes":{"opacity":[0,1]},"delay":5,"duration":2500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-35df45ed-690f-4131-80a2-f5c9e4def761","keyframes":{"transform":["translate3d(0px, 146.49287%, 0)","translate3d(0px, 0px, 0)"]},"delay":5,"duration":2500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Quarter 2 Result

[{"selector":"#anim-5215406b-ce4c-4509-a232-0adc5c340c52","keyframes":{"opacity":[0,1]},"delay":5,"duration":2500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f1b1dd7a-e0ee-41b1-897d-3ce4b2423072","keyframes":{"transform":["translate3d(0px, 191.71377%, 0)","translate3d(0px, 0px, 0)"]},"delay":5,"duration":2500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Price Action

[{"selector":"#anim-2aff6625-3497-4e5c-99d0-966015661469","keyframes":{"opacity":[0,1]},"delay":5,"duration":2500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c6fc8b3d-eb12-479e-b248-e718d6e4ae28","keyframes":{"transform":["translate3d(0px, 135.51303%, 0)","translate3d(0px, 0px, 0)"]},"delay":5,"duration":2500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

This small cap pharmaceuticals company has risen 13% after announcing its Q2 result.

This small cap pharmaceuticals company has risen 13% after announcing its Q2 result.

About the company

About the company

This company is Gland Pharma Ltd with market cap of Rs 26,399 crores.

Quarter 2 Result

Quarter 2 Result

Gland Pharma reported its revenue from operation in the July-Sep FY25 quarter of Rs 1,465 crore, and it grew by 2.36% QoQ.

Quarter 2 Result

Quarter 2 Result

Net profit grew by 25% QoQ from Rs 144 crores in Q1 FY25 to Rs 164 crores in Q2 FY25.

Price Action

Price Action

The share price of Gland Pharma is trading at Rs 1820 per equity share, up 13% from the previous day's closing of Rs 1610 per equity share

Liquor company jumps 17% after increasing 57% net profit QoQ.